A new study suggests that older men taking statins like Lipitor, which has been linked to new-onset Type 2 diabetes, may be less active than those not taking them, according to a study published in HealthDay News.
Results of the research were published in a June 9th issue of JAMA: Internal Medicine and indicate that statin users took part in about 40 less minutes of moderate activity each week, when compared to those not taking cholesterol-lowering medications similar to Crestor, Zocor, Lescol, Vytorin and Lipitor. The study’s conclusions are based on data from over 3,000 men aged 65 and older, draw comparison to those that previously found an increased drop in activity and the use of statins.
A quarter of the study’s participants, who were all recruited between 2000 and 2002, were already taking statins like Lipitor when the study was launched, and another quarter started taking them over a follow-up period of seven years. Half the men never took statins, according to the research.
Regardless of these findings, one of the study’s lead authors said people with high cholesterol should not abandon medications like Lipitor in efforts to reduce their risk of heart disease. “Statins are extremely helpful for people who need them,” said an assistant professor in the department of pharmacy practice at Oregon State University/Oregon Health and Science University’s College of Pharmacy in Portland.
“But the thing I want people to be aware of is that they can have some adverse effects on muscles that might lead to a decrease in exercise,” he later added in the JAMA: Internal Medicine report.
Statins may not only be associated with a lack of exercise though, according to court documents that reveal hundreds of lawsuits alleging Lipitor diabetes side effects n against its manufacturer, Pfizer Inc. As of June 2014, more than 800 lawsuits had been filed in a federal multidistrict litigation established in the U.S. District Court, District of South Carolina. The federal proceeding involves Lipitor diabetes lawsuits that similarly accuse Pfizer of failing to adequately warn patients about its link to new-onset Type 2 diabetes, even after the company was mandated to do so in February 2012 by the U.S. Food and Drug Administration (FDA).
According to claims, Lipitor’s updated warning label fails to properly warn about risks associated with the medication.
The attorneys at Bernstein Liebhard LLP may be able to help you file claim over Lipitor, a statin medication. Call the Firm at for more information.